2. Gene
  3. Pc - pyruvate carboxylase Gene

Pc - pyruvate carboxylase Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Rattus norvegicus

同用名: Pcx

基因 ID: 25104 | 基因类型: protein coding

关于 Pc

功能概要

Enables ATP binding activity; biotin binding activity; and pyruvate carboxylase activity. Involved in carboxylic acid metabolic process; gluconeogenesis; and positive regulation of phospholipid biosynthetic process. Located in mitochondrion. Human ortholog(s) of this gene implicated in pyruvate carboxylase deficiency disease. Orthologous to human PC (pyruvate carboxylase). [provided by Alliance of Genome Resources, Apr 2022]

Pc 基因产物(2)

mRNA Protein Name
NM_012744.3 NP_036876.2 pyruvate carboxylase, mitochondrial precursor
NM_012744.3 NP_036876.2 pyruvate carboxylase, mitochondrial precursor
基因本体论
  • 分子功能
  • 生物过程
分子功能 GO 注释 逻辑证据 参考文献 来源
enables ATP binding IDA
IDA: 通过直接分析推断
5773282 RGD
enables biotin binding IDA
IDA: 通过直接分析推断
12949377 RGD
enables biotin binding IMP
IMP: 通过突变表型推断
12949377 RGD
enables carboxylic acid binding IDA
IDA: 通过直接分析推断
15507531 RGD
enables pyruvate carboxylase activity IDA
IDA: 通过直接分析推断
4353083 RGD
enables pyruvate carboxylase activity IMP
IMP: 通过突变表型推断
12949377 RGD
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in gluconeogenesis IDA
IDA: 通过直接分析推断
4353083 RGD
involved in oxaloacetate metabolic process IDA
IDA: 通过直接分析推断
5773282 RGD
involved in positive regulation of phospholipid biosynthetic process IMP
IMP: 通过突变表型推断
23357280 RGD
involved in pyruvate metabolic process IDA
IDA: 通过直接分析推断
5773282 RGD
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

pyruvate carboxylase, mitochondrial

PCB

pyruvic carboxylase

相关产品

Approval
生物活性分子 (3)
目录号 产品名 作用方式
纯度 是否罕见病
HY-B0285 Amiloride 99.96% 是
HY-B0285A Amiloride hydrochloride 99.84% 是
HY-B0285B Amiloride hydrochloride dihydrate 99.88% 是
Clinical Phase
生物活性分子 (12)
目录号 产品名 作用方式
纯度 Phase
HY-B0285AR Amiloride hydrochloride (Standard) 99.80% Phase 4
HY-W783248 18:1(n10)-16:0 PC - IsoPure / Phase 4
HY-Y0284 Diethyl phthalate 99.87% Phase 3
HY-117766 PC945 Inhibitor 99.27% Phase 3
HY-156633 Rezatapopt p53 Activator 99.78% Phase 2
HY-17602 Amcasertib Inducer 98.03% Phase 2
HY-100186 GSK-2881078 Modulator 99.42% Phase 2
HY-102038 PC786 Inhibitor 99.11% Phase 2
HY-18696 AMG-337 99.40% Phase 2
HY-10254G Mirdametinib (GMP) Inhibitor / Phase 2
HY-133222 STX140 / Phase 2
HY-13626 Spisulosine 99.00% Phase 1
Pre-clinical Phase
生物活性分子 (477)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-W040193 DSPC 99.95% 否
HY-12364 C75 Inhibitor 99.91% 否
HY-130462 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC 99.91% 否
HY-N0615 Notoginsenoside R1 Inhibitor 99.93% 否
HY-125783 1-Palmitoyl-sn-glycero-3-phosphocholine 99.92% 否
HY-70072 D609 Inhibitor 98.0% 否
HY-P1028 Hexa-D-arginine 99.97% 否
HY-113123 LysoPC(14:0/0:0) 99.84% 否
HY-N9410 Lysophosphatidylcholine 18:2 99.12% 否
HY-153910 AGPS-IN-1 99.74% 否
HY-113253A N8-Acetylspermidine dihydrochloride 98.0% 否
HY-125771 1-Stearoyl-sn-glycero-3-phosphocholine 99.53% 否
HY-142870 ZY-444 99.51% 否
HY-130709 PROTAC CDK2/9 Degrader-1 Inhibitor 99.85% 否
HY-D1025 C-Phycocyanin / 否
HY-108361 CCG-203971 Inhibitor 99.89% 否
HY-Y1667 2,6-Dibromophenol Inhibitor 99.76% 否
HY-142684 Pyruvate Carboxylase-IN-1 Inhibitor 99.43% 否
HY-158790 (R)-HTS-3 Inhibitor 99.29% 否
HY-100014 KDM5A-IN-1 Inhibitor 99.64% 否
HY-101392 Harmane Inhibitor 99.91% 否
HY-124042 K6PC-5 99.27% 否
HY-149433 BWA-522 Inducer 99.93% 否
HY-126726 KOdiA-PC 99.00% 否
HY-W140439 1-Oleoyl-sn-glycero-3-phosphocholine 99.58% 否
HY-N3544 Caryophyllene oxide 99.71% 否
HY-N1353 Rhamnocitrin Inhibitor 99.67% 否
HY-16160 Cysmethynil 99.87% 否
HY-146985 Cathepsin X-IN-1 Inhibitor 99.62% 否
HY-156041 Lysophosphatidylethanolamines, egg 99.0% 否
HY-101947 SMI-16a Inhibitor 98.0% 否
HY-133968 24-Methylenecholesterol 99.48% 否
HY-143202 DPhPC 99.77% 否
HY-157544 PC5-VC-PAB-MMAE Inhibitor 99.76% 否
HY-B0927 Hydrastine Inhibitor 99.57% 否
HY-107416 RHC 80267 Inhibitor 99.41% 否
HY-N6601 Pomolic acid Inducer 99.97% 否
HY-W440982 SOPC 99.86% 否
HY-W440983 SDPC Activator 98.0% 否
HY-W748591 Cannflavin A 99.20% 否
HY-175023A OncoACP3 TFA Ligand 99.87% 否
HY-W329357 15:0 Lyso PC 99.6% 否
HY-138622 24:0 Lyso PC Chemical 99.70% 否
HY-138555 PROTAC BRD4 Degrader-8 Inhibitor 99.45% 否
HY-110166 PD 90780 99.0% 否
HY-140132 PC Biotin-PEG3-azide 97.75% 否
HY-171616 DCEM1 Inhibitor 99.31% 否
HY-W704966 2-Stearoyl-sn-glycero-3-phosphocholine 97.79% 否
HY-132197 CBP/p300-IN-12 Inhibitor 99.72% 否
HY-102067 3289-8625 Inhibitor / 否
HY-108016 Peruvoside 99.32% 否
HY-W414591 L-alpha-lysophosphatidylcholine, lauroyl 99.82% 否
HY-126359 1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine 98.0% 否
HY-142990 1-Oleoyl-2-palmitoyl-sn-glycero-3-PC 99.80% 否
HY-W040193S DSPC-d70 99.0% 否
HY-W322575 1,2-Diheptadecanoyl-sn-glycero-3-phosphorylcholine 99.0% 否
HY-141636 1-PalMitoyl-2-arachidoyllecithin 99.0% 否
HY-157698 1-1(Z)-Octadecenyl-2-arachidonoyl-sn-glycero-3-PC 99.0% 否
HY-149091 KDM5B-IN-4 Inhibitor 99.68% 否
HY-P1831 Proadrenomedullin (1-20), human 99.71% 否
HY-113123S1 LysoPC(14:0/0:0)-d7 95.4% 否
HY-12842 UC-112 98.92% 否
HY-157423 16:1 (DELTA 9-Cis) PC 99.0% 否
HY-119257 ABT-100 95.12% 否
HY-122678 LQZ-7F 97.13% 否
HY-146879S 26:0 Lyso PC-d4 95.60% 否
HY-153754 Phosphatidylcholine transfer protein inhibitor-1 98.01% 否
HY-P1028A Hexa-D-arginine TFA 98.42% 否
HY-121522 SD-70 Inhibitor 99.20% 否
HY-130462S 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 ≥99.0% 否
HY-140134 PC Biotin-PEG3-NHS ester 95.0% 否
HY-146331 PC190723 Inhibitor 98.34% 否
HY-147696 SMTIN-T140 99.58% 否
HY-153901 PROTAC EGFR degrader 8 Inhibitor 98.90% 否
HY-N8303 Gardenin A 97.61% 否
HY-W019833 MSPC 99.0% 否
HY-105118A Zaldaride maleate Antagonist 99.7% 否
HY-138635 PROTAC BRD4 Degrader-12 Inhibitor 98.54% 否
HY-150023 BI-1622 Inhibitor 98.97% 否
HY-P3320 Phytochelatin 3 99.34% 否
HY-157700 Hexadecenyl-2-hydroxy-sn-glycero-3-PC 99.40% 否
HY-165997 1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC 97.1% 否
HY-70083 SPK-601 Inhibitor 98.46% 否
HY-W275295 Perfluorododecanoic acid Activator 95% 否
HY-110260 LDN-193188 99.69% 否
HY-140138 PC SPDP-NHS carbonate ester 95.0% 否
HY-140139 PC Alkyne-PEG4-NHS ester 95.0% 否
HY-140140 PC Mal-NHS carbonate ester 95.0% 否
HY-142988 1-Stearoyl-2-myristoyl-sn-glycero-3-PC 98.0% 否
HY-146895S 14:0 Lyso PC-d27 99.0% 否
HY-165029 1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC 99.0% 否
HY-N5021 Anhydrosafflor yellow B 85.30% 否
HY-P3322 Phytochelatin 5 99.62% 否
HY-RS11190 PROC Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-131652 1,2-Di-O-hexadecyl-sn-glycero-3-phosphocholine 97.0% 否
HY-139931S 1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-PC 99.0% 否
HY-150135B D-myo-Inositol 1,4,5-trisphosphate tripotassium Activator 98.00% 否
HY-153725 17:1 Lyso PC 98.0% 否
HY-156778 Antitumor agent-120 96.0% 否
HY-W020809 C18(Plasm) LPC 99.0% 否
HY-W190937 PC Azido-PEG3-NHS carbonate ester 98.72% 否
HY-138634 GNE-987 GSH linker-2 Inhibitor 99.48% 否
HY-138632 PROTAC BRD4 Degrader-9 Inhibitor 98.23% 否
HY-103385 NCX4040 Inducer 99.82% 否
HY-108508 SMANT hydrochloride Inhibitor 99.90% 否
HY-125172 PolyQ aggregation inhibitor C2-8 Inhibitor 99.9% 否
HY-128536 KMG-104AM / 否
HY-131640 1,2-Didecanoyl PC 98.0% 否
HY-136704 GLS1 Inhibitor-1 Inhibitor 98.5% 否
HY-138622S1 24:0 Lyso PC-d4 95.0% 否
HY-138756 PC DBCO-PEG4-NHS ester 96.85% 否
HY-140142 PC Azido-PEG11-NHS carbonate ester 90.42% 否
HY-146840S 17:0-14:1 PC-d5 ≥99.0% 否
HY-147100 α1A-AR Degrader 9c Inhibitor 99.60% 否
HY-149149 Incadronic acid Inhibitor 98.03% 否
HY-157413 YS-67 Inhibitor 99.41% 否
HY-158310 SOS1/EGFR-IN-1 Inhibitor 99.54% 否
HY-163683 EB-PSMA-617 Inhibitor 96.38% 否
HY-N11001 Erinacine U 99.54% 否
HY-N4192 Toringin 99.62% 否
HY-N7972 19-Oxocinobufotalin 99.57% 否
HY-N9410S Lysophosphatidylcholine 18:2-d9 98.0% 否
HY-P1793 α-Casein (90-95) Agonist 99.51% 否
HY-P1793A α-Casein (90-95) TFA Agonist 99.58% 否
HY-P5272 Histatin-3 TFA Inhibitor 99.37% 否
HY-P5754B TAT-NEP1-40 acetate Inhibitor 94.33% 否
HY-RS07440 KRT17 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W127369 1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine 99.6% 否
HY-W127380 Arachidonoyl thio-PC ≥98.0% 否
HY-W440958 1-Palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine 99.90% 否
HY-101392A Harmane hydrochloride Inhibitor 99.35% 否
HY-122056 1,2-Diheptanoyl-SN-glycero-3-phosphocholine 99.47% 否
HY-13626S Spisulosine-d3 Inducer 99.0% 否
HY-138622S 24:0 Lyso PC-13C6 97.5% 否
HY-157647 1-Stearoyl-2-Adrenoyl-sn-glycero-3-PC / 否
HY-157666 13:0 PC 98.58% 否
HY-165157 1-1(Z)-Hexadecenyl-2-arachidonoyl-sn-glycero-3-PC 99.0% 否
HY-W040193S3 DSPC-d83 / 否
HY-W040193S4 DSPC-d4 99.0% 否
HY-W040221 Butanoyl PAF Agonist / 否
HY-158025 Anticancer agent 198 Inhibitor / 否
HY-N11605S C16(plasm)-18:1(d9) PC / 否
HY-125783S1 1-Palmitoyl-sn-glycero-3-phosphocholine-d31 99.0% 否
HY-125783S2 1-Palmitoyl-sn-glycero-3-phosphocholine-d49 / 否
HY-125783S3 1-Palmitoyl-sn-glycero-3-phosphocholine-d9-1 95.0% 否
HY-138633 PROTAC BRD4 Degrader-10 Inhibitor 99.75% 否
HY-138637 PROTAC BRD4 Degrader-14 Inhibitor / 否
HY-105118 Zaldaride Inhibitor / 否
HY-107640 WAY-170523 Inhibitor / 否
HY-11055 KP 544 / 否
HY-111266 Halenaquinone / 否
HY-111396 PC58538 Inhibitor / 否
HY-112661 PC-766B Inhibitor / 否
HY-113796 Kopsoffinol / 否
HY-115959 Anticancer agent 34 Inhibitor / 否
HY-115961 Anticancer agent 36 Inhibitor / 否
HY-115974 GRPR antagonist-1 / 否
HY-117517 NG-012 Activator / 否
HY-118147 ML356 Inhibitor / 否
HY-120561 PC-046 / 否
HY-121195 Apalcillin Inhibitor / 否
HY-121655 Dansyllysine / 否
HY-121679 COX-2-IN-50 Inhibitor / 否
HY-12364B (−)-C75 Inhibitor / 否
HY-123711 PC170942 Inhibitor / 否
HY-123715 Anticancer agent 255 / 否
HY-124152 3,4-Dephostatin Inhibitor / 否
HY-125010 Dicycloplatin Inducer / 否
HY-125554 KDdiA-PC Ligand / 否
HY-125744 Palmitoyl thio-PC / 否
HY-125771S 1-Stearoyl-sn-glycero-3-phosphocholine-d35 / 否
HY-125783S 1-Palmitoyl-sn-glycero-3-phosphocholine-d9 / 否
HY-129449 AnnH31 Inhibitor 99.91% 否
HY-130462S1 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d82 / 否
HY-133101 14-Norpseurotin / 否
HY-133233 Thioetheramide-PC Inhibitor / 否
HY-133968S1 24-Methylenecholesterol-13C / 否
HY-136480 Chrysamine G / 否
HY-136727A Ac-LEVD-CHO TFA Inhibitor / 否
HY-137348 10-Pyrene-PC / 否
HY-13847 GNE-555 Inhibitor / 否
HY-139231 1-Palmitoyl-2-formylyl PC / 否
HY-139294 PROTAC BRD4 Degrader-15 Inhibitor / 否
HY-140130 PC Biotin-PEG3-alkyne / 否
HY-140131 Biotin-PEG4-PC-PEG4-alkyne / 否
HY-140133 PC-Biotin-PEG4-PEG3-azide / 否
HY-140136 PC DBCO-PEG3-biotin / 否
HY-140141 PC Methyltetrazine-PEG4-NHS carbonate ester / 否
HY-140863 PC-PEG11-Azide / 否
HY-141863 Lepidozin G Inducer / 否
HY-142958 NF-κB-IN-2 / 否
HY-143445 EGFR-IN-48 Inhibitor / 否
HY-143641 Anticancer agent 25 / 否
HY-143882 MS5033 Inhibitor / 否
HY-143883 MS143 / 否
HY-144808 Anticancer agent 40 Inhibitor / 否
HY-146038 Antitumor agent-55 / 否
HY-146170 Anticancer agent 69 / 否
HY-146838S 17:0-18:1 PC-d5 / 否
HY-146839S 17:0-16:1 PC-d5 / 否
HY-146841S 19:0 Lyso PC-d5 / 否
HY-146841S1 (Rac)-19:0 Lyso PC-d5 / 否
HY-146848S C18(plasm)-18:1 PC-d9 / 否
HY-146849S 17:0-22:4 PC-d5 / 否
HY-146850S 17:0-20:3 PC-d5 / 否
HY-146880S 14:0-14:0 PC-d27 / 否
HY-146891S 16:0-16:0 PC-d31 / 否
HY-146893S 18:0-18:0 PC-d35 / 否
HY-146924S DL-Dipalmitoylphosphatidylcholine-d80 99.0% 否
HY-147682 NF-κB-IN-5 / 否
HY-147734 Calpain Inhibitor-2 Inhibitor / 否
HY-147852 B-Raf IN 7 Inhibitor / 否
HY-147853 B-Raf IN 8 Inhibitor / 否
HY-147854 B-Raf IN 9 / 否
HY-149434 PROTAC AR-NTD degrader 1 Inducer / 否
HY-149632 EGFR/HER2/DHFR-IN-2 Inhibitor / 否
HY-149729 ICMT-IN-53 Inhibitor / 否
HY-149976 Pim-1 kinase inhibitor 4 Inhibitor / 否
HY-149995 Pim-1 kinase inhibitor 5 Inhibitor / 否
HY-150563 Neuroinflammatory-IN-2 Inhibitor / 否
HY-151431 Nrf2/HO-1 activator 2 / 否
HY-151940 Mal-Pc Activator / 否
HY-152922 1-(1(Z)-Hexadecenyl)-2-linoleoyl-sn-glycero-3-phosphocholine / 否
HY-153051 Antitumor agent-90 / 否
HY-154861 Anticancer agent 118 / 否
HY-155049 NMDA receptor antagonist 6 Antagonist / 否
HY-155227A ALK/EGFR-IN-2 Inhibitor / 否
HY-155227B ALK/EGFR-IN-3 Inhibitor / 否
HY-155610 VEGFR-2-IN-32 Inhibitor / 否
HY-155718 fac-[Re(CO)3(L6)(H2O)][NO3] Inducer / 否
HY-155719 fac-[Re(CO)3(L3)(H2O)][NO3] Inducer / 否
HY-157125 PI3Kα-IN-14 / 否
HY-157394 eeAChE/eqBuChE-IN-1 Inhibitor / 否
HY-157437 AChE/BChE-IN-16 Inhibitor / 否
HY-157564 Antitumor agent-135 Inducer / 否
HY-157622 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine / 否
HY-157641A (2S)-18:1 Lyso PC / 否
HY-157689 1,2-Dieicosenoyl-sn-glycero-3-phosphocholine / 否
HY-157695 1-(1Z-Octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine / 否
HY-157696 18:0 Diether PC / 否
HY-157880 N3-PC / 否
HY-158328A CA IX/VEGFR-2-IN-2 / 否
HY-158373 Anticancer agent 213 Inducer / 否
HY-158710 1-Palmitoyl-2-pyropheophorbide a-sn-glycero-3-pc / 否
HY-159149 Antitumor agent-182 Inducer / 否
HY-159893 SMO-IN-5 / 否
HY-159972 PKR1 antagonist 1 Antagonist / 否
HY-160644 8PC / 否
HY-161502 DHX-SP / 否
HY-161627 Anemoside A3-methyl 6-aminohexanoate Inhibitor / 否
HY-161783 HDAC6-IN-45 / 否
HY-161785 EGFR-IN-117 Inhibitor / 否
HY-161859 VEGFR-2/STAT-3-IN-1 Inhibitor / 否
HY-161866 EGFR-IN-118 Inhibitor / 否
HY-162304 MAGL-IN-14 Inhibitor / 否
HY-162330 HDAC6-IN-36 Inhibitor / 否
HY-162380 Topoisomerase II inhibitor 18 Inhibitor / 否
HY-162751 Anticancer agent 249 / 否
HY-162812 H3R antagonist 4 Inhibitor / 否
HY-162885 YSY01A / 否
HY-162890 EGFR-IN-122 Inhibitor / 否
HY-162891 EGFR-IN-123 Inhibitor / 否
HY-162895 NL13 / 否
HY-163381 Antiproliferative agent-48 / 否
HY-163632 EGFR-IN-112 Inhibitor / 否
HY-165030 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PC / 否
HY-165086 PON-PC / 否
HY-165097 1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC / 否
HY-165616 NS 1231 / 否
HY-166989 1-undecanoyl-2-hydroxy-sn-glycero-3-phosphocholine / 否
HY-167571 12:0 Diether PC / 否
HY-167572 18:0 (9,10dibromo) PC / 否
HY-167573 16:0-10 Doxyl PC / 否
HY-167574 16:0-18:0(11-12BR) PC / 否
HY-167816 1,2-Diheneicosanoyl-sn-glycero-3-phosphocholine Inhibitor / 否
HY-168068 Res-Glu3 / 否
HY-168300 Antiangiogenic agent 7 / 否
HY-168371 1-Palmitoyl-2-13(S)-HODE-sn-glycero-3-PC / 否
HY-168372 1-Myristoyl-2-Linoleoyl-sn-glycero-3-PC Ligand / 否
HY-169006 Evo312 / 否
HY-169058 GSTP1-1 inhibitor 2 Inhibitor / 否
HY-169078 ML234 Inhibitor / 否
HY-169098 HSP90/LSD1-IN-1 Inhibitor / 否
HY-169414 WRN inhibitor 15 / 否
HY-170221 Chol-C10-PC / 否
HY-170386 TXY541 Inhibitor / 否
HY-170466 16:0-12 Doxyl PC / 否
HY-170933 SGK1-IN-6 Inhibitor / 否
HY-172366 BQ0413 / 否
HY-172481 DSPE-PEG1000-TAASGVRSMH / 否
HY-172482 DSPE-PEG2000-TAASGVRSMH / 否
HY-172482A DSPE-PEG3400-TAASGVRSMH / 否
HY-172483 DSPE-PEG5000-TAASGVRSMH / 否
HY-172562 BTR2004 Inhibitor / 否
HY-172748 9β-Hydroxyhexahydrocannabinol / 否
HY-172872 CDK2-IN-45 / 否
HY-172886 PI3K-IN-58 / 否
HY-173007 ALK/PI3K/AKT-IN-1 / 否
HY-173039 α-Tubulin polymerization-IN-1 / 否
HY-173122 Akt1-IN-8 Inhibitor / 否
HY-173597 ZINC43120769 Inhibitor / 否
HY-174397 EED-IN-3 Inhibitor / 否
HY-175017 Survivin-IN-2 Inhibitor / 否
HY-175023 OncoACP3 Ligand / 否
HY-175244 SOS1-IN-20 Inhibitor / 否
HY-175555 Tubulin-IN-54 / 否
HY-175826 USP30-IN-20 / 否
HY-175841 Tau Protein Phosphorylation-IN-1 Inhibitor / 否
HY-176284 OXPHOS-IN-2 / 否
HY-17638A Mizagliflozin (sebacate) Inhibitor / 否
HY-17654 BIEGi-1 Inhibitor / 否
HY-178045 MYC-IN-4 Inhibitor / 否
HY-178057 EGFR-IN-176 / 否
HY-178133 Pim-1 kinase-IN-14 / 否
HY-178485 SJY26 Inhibitor / 否
HY-179018 Topoisomerase II-IN-25 / 否
HY-179050 Androgen receptor-IN-7 / 否
HY-204056 Telomerase-IN-8 Inhibitor / 否
HY-403733C JJ-450 Antagonist / 否
HY-B0021S Doxifluridine-d2 / 否
HY-B0285AS Amiloride-15N3 hydrochloride / 否
HY-B0530A Azacyclonol hydrochloride / 否
HY-N10325 Sarbronine M / 否
HY-N10384 AChE-IN-17 Inhibitor / 否
HY-N10687 Saprorthoquinone / 否
HY-N11604 1-(1(Z)-Hexadecenyl)-2-palmitoleoyl-sn-glycero-3-phosphocholine / 否
HY-N11651 Peganumine A / 否
HY-N12004 19-Hydroxy-10-deacetylbaccatin III / 否
HY-N12123 Peimisine 3-O-β-D-glucopyranoside / 否
HY-N12124 Monascuspiloin 95% 否
HY-N12170 Kissoone C / 否
HY-N12225 Isoasiaticoside / 否
HY-N12466 3′-O-Demethyl-4′-N-demethyl-4′-N-acetyl-4′-epi-staurosporine Inhibitor / 否
HY-N12606 Neodidymelliosides A Inhibitor / 否
HY-N12821 visamminol-3'-O-glucoside / 否
HY-N13772 3'-O-Methyltaxifolin Inducer / 否
HY-N15711 Ganoleucoin R Inhibitor / 否
HY-N15785 18:0-Azo PC / 否
HY-N15792 18:1 Aminoethyl PC / 否
HY-N15810 18:0 Aminoethyl PC / 否
HY-N15919 a15:0-i15:0 PC / 否
HY-N15920 16:0-17:0 Cyclo PC / 否
HY-N15924 16:0-a15:0 PC / 否
HY-N15926 ent-POPC / 否
HY-N15928 16:0-i15:0 PC / 否
HY-N15933 16:0(Alkyne)-18:1 PC / 否
HY-N15937 IKS02 / 否
HY-N15948 18:0-16:0(16-Azido) PC / 否
HY-N15949 18:0 Carboxypentyl PC / 否
HY-N15955 18:1 Propargyl PC / 否
HY-N15957 18:0 Azidoethyl PC / 否
HY-N15966 18:0 Propargyl PC / 否
HY-N15984 18:1-12:0 Biotin PC / 否
HY-N15986 4ME 16:0 Diether PC / 否
HY-N15994 16:0-18:0(4,5-Dibromo) PC / 否
HY-N15996 16:0-18:0 (9-10BR) PC / 否
HY-N15997 14:0-14:0(COOH) PC / 否
HY-N16066 Candidusin A / 否
HY-N16426 Mycoleptone A Inhibitor / 否
HY-N3489 Isodihydrofutoquinol B / 否
HY-N3550 Catalponol / 否
HY-N3697 Demethoxydeacetoxypseudolaric acid B 99.94% 否
HY-N3928 Garciniaxanthone E / 否
HY-N3938 Gelsemiol / 否
HY-N4029 Humulene oxide II / 否
HY-N7535 Chlorovaltrate K / 否
HY-N8103 Heishuixiecaoline A / 否
HY-N9085 Neuchromenin / 否
HY-P10786 LinTT1 peptide Inhibitor / 否
HY-P11082 APGW-amide / 否
HY-P11313 Catestatin (rat) / 否
HY-P3321A Phytochelatin 4 TFA / 否
HY-P3322A Phytochelatin 5 TFA / 否
HY-P3323 Phytochelatin 6 / 否
HY-P3323A Phytochelatin 6 TFA / 否
HY-P5156 BDS-I Inhibitor / 否
HY-P5754 TAT-NEP1-40 Inhibitor / 否
HY-P5754A TAT-NEP1-40 TFA Inhibitor / 否
HY-P5876 Proadrenomedullin (N-20) (bovine, porcine) Antagonist / 否
HY-RS05191 G6PC1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05192 G6PC2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05193 G6PC3 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10111 PC Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10808 PODXL Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W019821 23:2 Diyne PC [DC(8,9)PC] / 否
HY-W019854 14:1 (Δ9-Trans) PC / 否
HY-W040172 06:0 Diether PC / 否
HY-W040193B (S)-DSPC / 否
HY-W040193S2 DSPC-d79 99.3% 否
HY-W040193S5 DSPC-d9 99.0% 否
HY-W040193S6 DSPC-d13 99.0% 否
HY-W331017 1-Hexacosanoyl-sn-glycero-3-phosphocholine / 否
HY-W339358 11:0 PC / 否
HY-W340037 1,2-Dibutyryl-sn-glycero-3-phosphocholine / 否
HY-W340113 15:0 PC / 否
HY-W403046A D-myo-Inositol-4-phosphate monoammonium Activator / 否
HY-W414749 08:0 Lyso PC / 否
HY-W440957 PMPC / 否
HY-W590535 19:0 PC / 否
HY-W700834 Harman-d3 / 否
HY-W713925 Diheptanoyl Thio-PC / 否
HY-W725397 23:0 PC / 否
HY-W725552 16:0-(12-PAHSA) PC / 否
HY-W748509 Pipernonaline / 否
HY-W753387 TopFluor-20:4 PC - IsoPure / 否
HY-W777360 Harman-13C2,15N Inhibitor / 否
HY-W783245 16:0-18:1(n10) PC - IsoPure / 否
HY-W783247 18:1(n7)-16:0 PC - IsoPure / 否
HY-W783249 20:4-16:0 PC - IsoPure / 否
HY-W800732 1,2-Dilinoleoyl-sn-glycero-3-PC / 否
HY-W800734 1-Myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine / 否
HY-W800785 16:0-23:2 Diyne PC / 否
HY-W923483 C16-18:1 PC / 否
HY-115731 Tocol / 否
HY-121619 Jacaric acid Inducer / 否
HY-125783R 1-Palmitoyl-sn-glycero-3-phosphocholine (Standard) / 否
HY-130462S2 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-13C16 / 否
HY-130462S3 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d64 / 否
HY-134225 1-O-Hexadecyl-2-arachidonoyl-sn-glycero-3-PC / 否
HY-137126 Photosensitizer Pc 4 Inhibitor / 否
HY-137225 HTS07944 / 否
HY-137325A 2-Chloro-ATP sodium / 否
HY-141636S 1-PalMitoyl-2-arachidoyllecithin-d9-1 / 否
HY-143857S 22:0 Lyso PC-13C6 / 否
HY-144086S 22:0 Lyso-PC-d4 / 否
HY-145547 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine / 否
HY-146925S 15:0 Lyso PC-d5 / 否
HY-14830 SAR 97276 Inhibitor 98.05% 否
HY-149715 R1-11 Inhibitor / 否
HY-157404 Pim-1/2 kinase inhibitor 2 Inhibitor / 否
HY-157423A 16:1 (DELTA 9-Cis) PC,chloroform / 否
HY-157672 18:1-14:0 PC / 否
HY-157675 1,2-Dinervonoyl-sn-glycero-3-phosphocholine / 否
HY-159118 PC-Qz1 Inhibitor / 否
HY-164164 16:0-16:0(Acrylate) PC / 否
HY-164283 DOCP / 否
HY-164621 A3AR antagonist 5 Antagonist 98.17% 否
HY-165430 Antiviral agent 67 / 否
HY-165663S 1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC / 否
HY-167585S 16:0-18:2 PC-d5 / 否
HY-167586S 18:0-22:6 PC-d9 / 否
HY-168373 1-Stearoyl-2-Eicosapentaenoyl-sn-glycero-3-PC / 否
HY-168757 PSMA precursor-1 Ligand / 否
HY-168796 1-Palmitoyl-2-13(S)-HpODE-sn-glycero-3-PC / 否
HY-169476 Pyrrolidine linoleamide / 否
HY-169830 2-(Cyclohexylmethyl)-plumbagin / 否
HY-176085 Heptanoyl thio-PC Substrate / 否
HY-178040 Insecticidal agent 26 Inhibitor / 否
HY-B0285S Amiloride-15N3 / 否
HY-N1107 Uzarigenin / 否
HY-N12001 6-Epiagarotetrol / 否
HY-N14417 Indocarbazostatin / 否
HY-N14424 Indocarbazostatin B / 否
HY-N3562 Cedrin Inhibitor / 否
HY-N3563 Celaphanol A / 否
HY-N9257 8-Hydroxypinoresinol4,4'-di-O-β-D-glucopyranoside / 否
HY-N9861 Kayaflavone Inhibitor / 否
HY-RS16637 pc Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS17167 Proc Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS18605 Cbx2 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS19229 Podxl Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS20932 G6pc3 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23072 Pc Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS25718 Podxl Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27449 G6pc3 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W040193GL DSPC (GMP Like) / 否
HY-W040193S1 DSPC-d74 / 否
HY-W292927 (E)-Antiviral agent 67 Inhibitor / 否
HY-W437569 Melicopine Inhibitor / 否
HY-W440982A (Rac)-SOPC / 否
HY-W725327 1,2-Dipropionyl-sn-glycero-3-phosphocholine / 否
HY-W725399 1,2-Dilignoceroyl-sn-glycero-3-phosphocholine / 否
HY-W753474 1,2-Dipalmitelaidoyl-sn-glycero-3-phosphocholine / 否
HY-W778562 10-Deacetyl-13-oxobaccatin III / 否
HY-W783246 16:0-18:1(n7) PC - IsoPure / 否
HY-W839203 22:0 PC / 否
HY-19378 MIV-150 Inhibitor / 否
抗体抑制剂 (2)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P990281 Anti-Mouse CD25/IL-2Rα Antibody (PC-61.5.3) 95.00% 否
HY-P991316 KD014 96.98% 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Pc NCBI NCBI:5091
Canis familiaris Pc NCBI NCBI:483704
Macaca fascicularis Pc NCBI NCBI:102146568
Mus musculus Pc NCBI NCBI:18517
Susscrofa domestica Pc NCBI
Macaca mulatta Pc NCBI NCBI:713103
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z